HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine.

Abstract
We examined the effects of late administration of the thromboxane synthetase inhibitor dazmegrel (UK 38485) and the calcium channel blocker nifedipine in anaesthetised greyhounds subject to occlusion of the left anterior descending coronary artery with reperfusion after 40 min of ischaemia. Administration of dazmegrel, 3 mg/kg i.v., or nifedipine, 5 micrograms/kg + 1 microgram kg-1 min-1 i.v., 25 min after coronary artery occlusion failed to reduce the incidence of reperfusion-induced ventricular fibrillation (controls, 70%; dazmegrel, 50%; nifedipine, 70%; n = 10). Measurement of plasma prostanoid concentrations indicated that within 5 min of receiving dazmegrel there was a significant reduction in thromboxane B2 concentrations in the local coronary vein draining the ischaemic myocardium. The results suggest that the occurrence of reperfusion-induced ventricular fibrillation depends upon the severity of changes occurring during ischaemia. Analysis of various factors suggested that the number of ischaemia-induced arrhythmias, heart rate, and the magnitude of changes in local coronary venous PO2 may be important predictors of reperfusion-induced ventricular fibrillation.
AuthorsS J Coker, J R Parratt
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) 1985 Mar-Apr Vol. 7 Issue 2 Pg. 327-34 ISSN: 0160-2446 [Print] United States
PMID2581088 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Imidazoles
  • dazmegrel
  • Oxidoreductases
  • Thromboxane-A Synthase
  • Nifedipine
Topics
  • Animals
  • Blood Gas Analysis
  • Coronary Disease (physiopathology)
  • Dogs
  • Female
  • Hemodynamics (drug effects)
  • Hydrogen-Ion Concentration
  • Imidazoles (administration & dosage, pharmacology, therapeutic use)
  • Male
  • Nifedipine (administration & dosage, pharmacology, therapeutic use)
  • Oxidoreductases (antagonists & inhibitors)
  • Perfusion
  • Thromboxane-A Synthase (antagonists & inhibitors)
  • Ventricular Fibrillation (etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: